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Abstract.  We have used a monoclonal antibody raised 
against rat liver nuclear proteins to study two cross- 
reactive proteins in the yeast nucleus. In rat liver,  this 
monoclonal antibody, mAb 414,  binds to nuclear pore 
complex proteins,  including one of molecular weight 
62,000 (Davis,  L. I., and G.  Blobel.  1987. Proc.  Natl. 
Acad.  Sci.  USA.  84:7552-7556).  In yeast, mAb 414 
cross reacts by immunoblotting with two proteins that 
have apparent molecular weights of 110,000 and 
95,000,  and are termed p110 and p95,  respectively.  Ex- 
amination of subcellular fractions by immunoblotting 
shows that both pll0 and p95 are located exclusively 
in the nuclear fraction. The mAb 414  immunoprecipi- 
tates several  proteins from a crude yeast cell extract, 
including pll0, p95,  and a  ,x,55-kD protein. Immuno- 
precipitation from subcellular fractions yields 
only p110 and p95  from purified nuclei, whereas the 
~55-kD protein is immunoprecipitated from the solu- 
ble fraction. Digestion of purified nuclei with DNase 
to produce nuclear envelopes releases some of pll0, 
but the majority of pll0 is solubilized only after treat- 
ment of envelopes with  1 M  NaCI. Immunofluores- 
cence localization using yeast cells and isolated nuclei 
shows a punctate and patchy staining pattern of the nu- 
cleus. Confocal laser scanning immunofluorescence 
microscopy resolves the punctate and patchy staining 
pattern better and shows  regions of fluorescence at the 
nuclear envelope. Postembedding immunogold electron 
microscopy using purified nuclei and mAb 414 shows 
colloidal gold decoration of the yeast nuclear enve- 
lope, but resolves pore complexes too poorly to 
achieve further ultrastructural localization. Im- 
munogold labeling of nuclei followed by embedding 
suggests  decoration of pore complexes. Thus, pll0 
and/or p95  are localized to the nuclear envelope in 
yeast, and may be components of the nuclear pore 
complex. 
T 
o a large extent, the nucleus is defined as an organelle 
by a boundary known as the nuclear envelope, which 
consists  of an inner  and outer  membrane  and  pore 
complexes. The two membrane bilayers of the nuclear enve- 
lope unite at nuclear pores, yet each retains specific struc- 
tural and functional specializations. The inner membrane is 
linked to the nuclear lamina (8, 12, 21, 29). The outer mem- 
brane  is enriched  in certain  enzymes,  such as HMG-CoA 
reductase, for example, in both higher and lower eucaryotes 
(24, 30). The nuclear pores contain large, protein-containing 
structures known as pore complexes (8). The pore complex 
is known to mediate and regulate the vectorial transport of 
protein and RNA molecules into and out of the nucleus (5, 
6). In this way, the pore complex provides a channel for mo- 
lecular communication between the nucleoplasm and cyto- 
plasm.  Many aspects of the biology of the nuclear envelope 
have been addressed (see reviews in references 5, 12, 15,  17, 
20, 21). 
The pore  complex  is  a  large  supramolecular  structure, 
having a diameter of ,~70-100  nm, and its dimensions ap- 
pear to be conserved across many phyla (17). One of the sali- 
ent features  of pore  ultrastructure  is  its distinct  eightfold 
symmetry when viewed enface (8, 26). Recently, the struc- 
ture of the pore complex has been determined at a resolution 
of'~9 nm (26). The pore complex contains an aqueous chan- 
nel, which has a functional diameter of •11  nm, based on 
the measurement of diffusion of molecules through the pore 
(16). The transport of proteins >*40 kD across the pore is 
thought to involve a mechanism that recognizes nuclear tar- 
geting sequence information (5, 16). With an estimated mass 
of 25-50  ×  106 D, the pore complex is thought to contain 
many protein,  as well as RNA, components (12, 25). 
A number of  protein components of  the pore complex have 
been identified in higher eucaryotes. A membrane glycopro- 
tein, gp190, was identified in rat liver, and may serve to an- 
chor the pore complex in the nuclear envelope (13). The pri- 
mary structure  of this  glycoprotein  has  been  determined 
recently (29a). A pore complex protein of 62,000 molecular 
weight, p62, has been identified using monoclonal antibod- 
ies (3, 4) and an assay for pore function (7). p62 is a member 
of a family of proteins that are posttranslationally  modified 
with O-linked N-acetyl-glucosamine  (3,  4,  7,  10,  11,  25). 
Certain  monoclonal  antibodies  against pore  complex pro- 
teins may recognize an epitope containing this sugar (3,  11, 
23, 25). The inhibition of macromolecular  transport across 
the pore with wheat germ agglutinin suggests a direct role 
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are characterized by this saccharide linkage includes proteins 
covering a broad range of relative molecular mass: 62-270 kD 
(3, 4); 45-210 kD (11, 25); or 35-110  kD (23). 
Pore complexes in actively growing yeast cells appear to 
have a normal diameter (,x,100 nm), and are present at a fre- 
quency ("~11 pores/~m  2) identical to that in many other cell 
types (14,  18). Interestingly, slow growth or growth arrest 
results in fewer pores per nucleus or an increase in pore di- 
ameter (14, 28). Pore synthesis during interphase of the yeast 
cell cycle may be comparable to that in higher eucaryotes (14, 
19, 22). In addition, yeast provides an opportunity to study 
a nuclear envelope and pore complex that do not appear to 
disassemble during "closed" mitosis (2, 9).  The identifica- 
tion of pore complex proteins in rat liver has provided us with 
an experimental approach to studying this structure in yeast 
(3, 4). We have used a monoclonal antibody that recognizes 
p62 to search for cross-reactive proteins in the yeast nucleus. 
As a result, we have identified two new proteins localized to 
the yeast nuclear envelope, and present evidence that these 
proteins may be further localized to nuclear pore complexes. 
Materials and Methods 
Yeast Strains, Reagents, and Materials 
The protease-deficient haploid Saccharomyces cerevisiae strain BJ2168 (a, 
prcl-407,  prbl-1122, pep4-3,  leu2,  trpl,  ura3-52)  was obtained from the 
Yeast Genetic Stock Center (Berkeley,  CA). The standard Fleischmann's 
yeast strain was purchased at Sloan's Supermarket, New York.  Lyticase, 
DNase I (type DN-EP), and 4',6-diamidino-2-phenylindole (DAPI) I were 
from Sigma Chemical Co. (St. Louis, MO). IgGsorb was from the Enzyme 
Center (Malden,  MA).  DL-dithiothreitol (DTT)  and TX-100  were from 
Boehringer Mannheim Biochemicals (Indianapolis, IN). Affinity-purified 
goat anti-mouse 5- and 10-rim colloidal gold were obtained from Janseen 
Life  Sciences  Products  (Piscataway,  NJ).  Fluorescein-conjngated goat 
anti-mouse antibody was from Organon Teknika-Cappel, (Malvern, PA). 
En3Hance and t25I-protein A (2-10 #Ci/mg) were from Du Pont New En- 
gland  Nuclear Research Products (Wilmington, DE).  Paraformaldehyde 
(EM  grade), glutaraidehyde (EM grade),  polylysine hydrobromide, and 
uranyl acetate were from Polysciences, Inc. (Warrington, PA).  LR White 
(medium) embedding resin was from the London Resin Co., Ltd. (Surrey, 
England). Resin LX-I12 was from Ladd Research Industries, Inc. (Burling- 
ton, VT). SDS was obtained from BDH Chemicals Ltd. (Poole, England). 
Ficolt 400 was from Pharmacia Fine Chemicals (Piscataway,  NJ). All other 
chemicals, reagents, and media components were obtained from customary 
scientific vendors and were of high purity. 
Purification of Nuclei 
Nuclei were purified from the protease deficient strain BJ2168 as described 
(1), with the following modifications. Protease inhibitors were diluted from 
stock cocktails (1,000x) made in water (W) or DMSO (D) to final concen- 
trations of: 1 mM ~-aminocaproic acid (W), 5/~g/ml aprotinin (W), 1 mM 
p-aminobenzamidine (W),  1 /zg/ml  chymostatin (D),  1 /~g/ml leupeptin 
(W), 5 ttg/rnl pepstatin (D), 250 #M PMSF (D), and 50/~M p-chloromer- 
curiphenyl sulfonie acid (D). The L, S, and H fractions harvested from the 
gradient used to purify nuclei were subjected to further purification than pre- 
viously described (1). The L and H membrane fractions were diluted 1:10 with 
the 20% Ficoll buffer, homogenized, and centrifuged a second time for 1 h 
at  18,000 rpm in a rotor (model SW28;  Beckman Instruments Inc., Palo 
Alto, CA) (1). The S fraction was centrifuged likewise without dilution. The 
L, H, and S fractions were harvested and stored at -80°C as described (1). 
Digestion and Extraction of Nuclei 
DNase I digestions and extractions were conducted as described (1), with 
1. Abbreviations used in this paper:  CLS, confocal laser scanning; DAPI, 
4',6-diamidino-2-phenylindole. 
modifications. Digestion with DNase was done in PMS buffer: 20 mM 
KPi, pH 7.0, 0.1  mM MgCI2,  250 mM sucrose. For extractions, nuclear 
envelopes were resuspended by homogenization in PES buffer: 20  mM 
KPi, pH 7.0, 1 mM EDTA, 250 mM sucrose. Extraction with salt was done 
by adding an equal volume of PEN buffer: 20 mM KPi, pH 7.0,  1 mM 
EDTA, 2 M NaCI. DTT (1 M) was freshly added to a final concentration 
of 1 mM in all buffers. Protease inhibitors were freshly added to the same 
final concentration used for the isolation of nuclei. 
SDS-PAGE and lmmunoblotting 
SDS-PAGE was carried out with 8-14% gradient, or 10.5% polyacrylamide 
slab gels as described previously (1). For immunoblotting, proteins were 
electrophoretically transferred to nitrocellulose, and processing was done 
as previously described (1). The mAb 414 supernatant was diluted 1 in 20 
with the standard immunoblotting buffer (1). Results were visualized by in- 
cubation with t2SI-protein A, followed by autoradiography. 
Immunoprecipitation opJS-labeled Proteins  from Yeast 
For immunoprecipitations from lysates of whole yeast, strain BJ2168 was 
grown to an OD600 of 0.25 at 30"C in 20 ml of SD+  medium: 2% dex- 
trose, 0.67 % yeast nitrogen base without amino acids, plus 25 t~g/ml of leu- 
cine, tryptophan, and uracil. The yeast were chilled on ice, washed twice, 
and resuspended in 4 ml of SD+ medium. Yeast were labeled for 90 min 
at 30°C after the addition of 0.4 mCi (0.36  nmol) of [35S]methionine.  La- 
beled yeast were chilled on ice and washed twice with cold IP buffer: 50 
mM Tris, pH 7.5,  150 mM NaC1,  1 mM EDTA, 2 mM NAN3. All buffers 
below contained protease inhibitors (see nuclei purification above). Yeast 
were resuspended in 0.2 ml of IP buffer plus 1% SDS, 1 mM DTT, and lysed 
by vortexing for 2  min in a  13  ×  100-ram  glass tube With 0.2 g of acid 
washed glass beads. The lysate was boiled 2 min, diluted with 0.8 ml of IP 
buffer plus 1% TX-100, 2 mM iodoacetamide, and placed on ice. The lysate 
was centrifuged at 500 g for 5 min, transferred to a microfuge tube and cen- 
trifuged at 12,000 g for 5 min at 4°C. The lysate was precleared in the cold 
for 1-2 h by transferring 1.0 ml to a microfuge tube containing 0.1 ml of 
washed and blocked IgGsorb. After a  10-min spin at 12,000 g, "~4}.9 ml of 
supernatant was diluted 10-fold with IP buffer plus 1% TX-100, 0.2% SDS. 
Each immunoprecipitation was done with "~1  ml of the diluted lysate. 
To purify 3~S-labeled  nuclei, BJ2168  was grown in  100 ml of YPD at 
30°C to an OD600 of 1.0. The yeast (~0.1  g) were washed twice with SP 
medium (without added amino acids; reference 1) and resuspended in 0.9 
ml of SP medium containing 2 mM DTT,  0.4 mg Lyticase, and 2 mCi of 
[35S]methionine.  The yeast were labeled and digested for 60 min at 30"C. 
Nuclei were purified using a  scaled down version of our previously de- 
scribed method (1). Instead of two spins in the rotor (model HB-4; Sorvall 
Instruments Div., Newton, CT), a single spin was done in a rotor (model 
TLS-55;  Beckman  Instruments Inc.)  for 3  min  at  12,000  rpm (12,300 
gmax). A small aliquot of the supernatant was collected for the cleared ly- 
sate (CL) fraction. A 2.2-ml step gradient was centrifuged in the TLS-55 
rotor for 15 rain at 25,000  rpm (53,600 gm~)- Purified nuclei and the solu- 
ble fraction were collected from the step gradient as usual. For immunopre- 
cipitation, the crude lysate, soluble, or nuclear fractions (5  x  106 cpm 
each) were dissolved in a final volume of 0.2 ml of IP buffer plus 1% SDS, 
2 mM DTT.  Labeled nuclei were washed once in 20 mM KPi, pH 6.5,  1 
mM MgCI2 before lysis. The samples were boiled 2 min and processed as 
described above. The precleared lysate was not diluted before use. 
For each immunoprecipitation, 0.5 ml of the mAb 414 was preincubated 
with 15/xl of blocked protein G-Sepharose, and subsequently washed. The 
incubation with antibody was done overnight in the cold. The immunopre- 
cipitate was washed sequentially at room temperature twice with: IP buffer 
plus 1% TX-100, 0.2% SDS; 1P buffer plus 1% TX-100, 2 M urea: IP buffer 
alone. The samples were prepared fur SDS-PAGE as usual after washing 
once with 10 vol of water. Gels were fluorographed with En3Hance and 
placed against x-ray film. 
lmmunofluorescence Microscopy 
A standard Fleischmann's yeast strain and strain BJ2168 were used accord- 
ing to methods previously described (1). Glutaraldehyde fixation was not 
done. The monoclonal supernatant was neutralized by adding 1 M Hepes 
acid to 25  mM.  Fluorescein-conjugated goat anti-mouse antibody was 
preadsorbed with fixed, digested, permeabilized, and blocked yeast cells 
and applied at a final dilution of I in 200 (1). Specimens were observed with 
a Bio-Rad Lasersharp MRC-500 confocal laser scanning microscope, or a 
Zeiss Axiophot microscope using a 100×  Plan-Neofluar objective, and im- 
ages were recorded with Kodak Plus X or T-MAX film. 
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Nuclei were embedded in the hydrophilic  resin LR White as previously de- 
scribed (1) after fixation with cold 3 %  p-formaldehyde  and 0.2 % glutaraide- 
hyde in 50 mM KPi, pH 6.5, 1 mM MgCI2. Ultrathin sections on nickel 
grids were etched 15 rain in fresh 10% NaIO4. Incubations  with antibody 
reagents and wash buffers were done as described (1) with the following 
modifications. All buffers contained TX-100 (0.01%). Before staining with 
uranyl acetate, the samples were cross-linked with 2% glutaraldehyde in 
PBS. Staining with Reynolds  lead was omitted. For preembedding  immuno- 
electron microscopy, purified nuclei suspended in Ficoll buffer (1) were 
fixed by diluting 10-fold  with cold 20 mM KPi, pH 6.5, 1 mM MgCI2, 3% 
p-formaldehyde, 0.1% glutaraldehyde. Nuclei in fixative (1 ml/slide) were 
incubated in the cold overnight in multichambered slides (Titertek, Elfab 
Oy, Finland), previously coated with polylysine (1). The fixative solution 
was replaced by cold PBS, 1 mM MgCl2, 3% p-formaldehyde,  0.1% glutar- 
aldehyde, and fixation was continued 1 h. The slide was placed  at room tem- 
perature for 1 h. The samples were washed three times with PBS with 1 
mM MgCI2, with 50 mM NH4CI in the second wash. Permeabilization 
with 0.1% TX-100  was done for 5 min at room temperature (1). Incubation 
with antibody reagents and washing buffers was done as described (1). Goat 
anti-mouse 5-nm colloidal gold was used at a 1:20 dilution. Conventional 
methods were used for fixation with glutaraldehyde, postfixation with 
osmium tetroxide, embedding in LX-112 resin, ultrathin sectioning, and 
staining (1). Specimens  were  visualized with a JEOL 100CX  electron micro- 
scope at 60 kV, and photographs  were recorded  with Kodak  electron micro- 
scope film. 
Results 
A  Monoclonal Antibody against Rat Liver Pore 
Complex Proteins Recognizes Two Proteins in the 
Yeast Nucleus 
The monoclonal antibody (mAb) 414 was previously shown 
to react with three proteins  of M, 62,  175, and 270 kD (3, 
4).  Results  from immunofluorescence and immunoelectron 
microscopy demonstrated localization of the protein(s) to the 
pore complex in mammalian cells  (3,  4).  Our preliminary 
results suggested that at least one protein on immunoblots of 
yeast nuclear proteins cross-reacted with the 414 monoclonal 
antibody. Further analysis has shown that two proteins bind 
with high-atfinity to mAb 414 on immunoblots of proteins 
from purified  nuclei  (Fig.  1  A).  The  apparent  molecular 
masses on SDS gels of these two proteins are approximately 
110,000 and 95,000 D. These two proteins are referred to as 
p110 and p95,  respectively. 
We examined the intracellular distribution of p110 and p95 
by probing the cell fractions that result from the purification 
of yeast nuclei (1). These fractions are: purified nuclei (N); 
the low and high density membrane fractions (L and H); and 
the soluble fraction (S).  The L, S, and H  fractions are ob- 
tained from a yeast spheroplast lysate after Ficoll step gra- 
dient centrifugation (see Materials and Methods).  Virtually 
all of the proteins of the yeast lysate are represented  in the 
combination of these three fractions,  with the exception of 
cell wall components. Immunoblotting shows that essentially 
all of pll0 and p95 occur in the nuclear fraction (Fig.  1 B). 
The nonnuclear fractions L, S, and H do not contain detect- 
able amounts of pll0 or p95 (Fig.  1 B).  Long exposures of 
the autoradiogram show that mAb 414 detects a  protein of 
,v55  kD in the S  fraction (not shown). 
To extend  the  characterization  of the  cross-reactivity  of 
mAb 414 in yeast, we did immunoprecipitation experiments. 
Using  a  crude  lysate  from  [35S]methionine-labeled  yeast 
shows that mAb 414 immunoprecipitates  a  number of pro- 
teins, including bands of  apparent mol wt 110,000 and 95,000 
(Fig. 2, lane 2).  A  prominent protein band of •55  kD was 
also immunoprecipitated (Fig. 2, lane 2). This band may in- 
clude a group of  proteins migrating close together in the SDS 
gel. To distinguish between nuclear and soluble proteins rec- 
ognized by mAb 414, we did immunoprecipitations with sub- 
cellular fractions from labeled  yeast.  Nuclei  were purified 
Figure 1. The monoclonal antibody 414 recognizes 
two proteins in the yeast nucleus. (A) Yeast nuclear 
proteins were separated  by 8-14% gradient SDS- 
PAGE and probed by immunoblotting with mAb 
414  (N).  ~4C  molecular  mass  standards  (Mr  x 
10  -3)  were present on the immunoblot (M).  (B) 
Yeast nuclear proteins (N, t00 t~g), and the subcel- 
lular fractions  L, S, H (33/zg) were separated  by 
10.5%  SDS-PAGE  and  stained  with  Coomassie 
blue (CBS), or probed by immunoblotting as in A 
(414), The stained  molecular mass standards  are 
identical  to those in A without the tac label.  His- 
tones are marked by dots. 
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released by digestion with DNase (Fig. 3). The reduced de- 
tectability of p95 during fractionation of nuclei has been ob- 
served in more than one experiment, and the reason for this 
is not known.  Envelopes washed with a high concentration 
of NaCI (1 M) are completely free of residual histones, and 
are substantially free of a number of other proteins, includ- 
ing the  nucleolar protein p38  (1). The majority of pll0  is 
found  in  the  supernatant  fraction after washing  envelopes 
with a high salt buffer (Fig. 3). A small amount of pll0 oc- 
curs in the salt-washed envelope fraction. Thus, the majority 
of pll0 appears in the envelope and salt wash fractions, al- 
though the partitioning is not quantitative. 
lmmunofluorescence Localization in Yeast Cells and 
Purified Nuclei 
With an interest in confirming the data from immunoblotting 
and  immunoprecipitation,  we did  indirect  immunofluores- 
cence using the mAb 414. The immunofluorescence obtained 
with mAb 414 gives a distinctly nuclear pattern of staining 
in yeast cells (Fig. 4).  Counter staining with DAPI clearly 
shows coincidence of the portion of the nucleus containing 
chromatin with the fluorescein signal.  The area exhibiting 
Figure  2. Immunoprecipitation of pll0 and p95 with mAb 414. The 
immunoprecipitates  obtained using mAb 414, or a control  using 
no primary antibody  (C),  from an  35S-labeled lysate of whole 
yeast are shown (lanes 2 and 3). Immunoprecipitates from identical 
amounts (in cpm) of 35S-labeled nuclei (N), soluble proteins (S), 
or a cleared lysate (CL), are shown (lanes 5-8).  Samples of the 
corresponding  supematants  (SN) are equal  to  1  ×  10  -3 of the 
original  volume. Samples were electrophoresed  on a  10.5% gel. 
Lanes 6-8 are from an overexposed fluorogram to show pll0 and 
p95 in the CL, but not the S, fraction. Filled and open arrows point 
to pll0 and p95. t4C molecular mass standards are the same as in 
Fig.  1. 
from  [35S]methionine-labeled  yeast using  a  modified  ver- 
sion of a previously described procedure (1). Immunoprecip- 
itation was done using: purified nuclei (N); a soluble fraction 
(S); and a lysate cleared by a low speed centrifugation step 
(CL). The mAb 414 immunoprecipitates pll0 and p95 from 
the nuclear fraction, but essentially none of the 55-kD pro- 
tein(s), nor the minor band at 51 kD (Fig. 2, lanes 5-8). The 
proteins between 50 and 55 kD are solely present in the im- 
munoprecipitate from the soluble fraction, and none of pll0 
or p95 appear to coimmunoprecipitate with the 50-55-kD 
proteins. 
Fractionation of Yeast Nuclei and the 
Disposition of  pllO 
To investigate some of the intranuclear interactions involving 
pll0 and p95, we fractionated nuclei using a method previ- 
ously described  (1). Digestion of nuclei  with  DNase in  a 
buffer containing a low concentration of MgC12 is followed 
by centrifugation which separates nuclear envelopes into the 
pellet fraction.  DNase digestion yields essentially pure nu- 
clear envelopes, free of the majority of the chromatin, as in- 
dicated by the partitioning of "o90% of the histones into the 
supernatant fraction (Fig. 3). Approximately 70 % of p110 is 
Figure 3. Subfractionation of purified nuclei. Nuclei (100 t~g pro- 
tein) were washed (W, wash fraction), digested with DNase (D), and 
centrifuged to generate a supernatant fraction (S) and nuclear enve- 
lopes (P). Nuclear envelopes were extracted with 1 M NaCI (Na) 
and centrifuged  to give supernatant  (S) and pellet  (P) fractions. 
Samples  were electrophoresed  on a  10.5% gel and stained with 
Coomassie  blue  (CBS) or immunoblotted  with  mAb 414 (414). 
Filled and open arrows point to pll0 and p95. Histones are marked 
by dots. 
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body was done using a standard method with Fleischmann's yeast (a-c,  i), the haploid strain BJ2168 (d-f),  or with isolated nuclei (g 
and h). The corresponding  DAPI staining of chromatin (b and e) and the DAPI staining plus Nomarski optics image (c and f) are shown. 
Control  panels of nuclei (Cn) or yeast cells (C0 are from samples not treated with antibody  (h and i). Bar, 4 #m. 
immunofluorescence is greater than that seen with DAPI be- 
cause  a  large  portion  of the  nucleus  is  occupied  by  the 
nucleolus,  which  does  not  accumulate  DAPI.  In dividing 
pairs of yeast, the immunofluorescence extends through the 
bud neck between the chromatin masses (Fig. 4 a). The im- 
munofluorescence localization with mAb 414 in the Fleisch- 
mann's yeast is  identical  to that  seen in the  haploid  strain 
BJ2168 (Fig. 4, d-f).  Strain BJ2168 has a smaller cell size, 
contains  a  small nucleus,  and gives a  correspondingly re- 
duced distribution  of immunofluorescence.  Nuclei purified 
from BJ2168 show a fluorescence staining pattern compara- 
ble to that observed in the whole cells (Fig. 4, g and h). The 
fluorescence pattern is heterogeneous, with staining intensity 
at the nuclear envelope, as well as at the nuclear interior. In 
all  nuclei  many discrete points of fluorescence can be ob- 
served, in addition to larger patches of staining. A faint cyto- 
plasmic staining  is also visible in the yeast cells,  and may 
correspond  to  the  intracellular  distribution  of the  soluble 
proteins recognized by mAb 414. 
To visualize the  immunofluorescence staining pattern in 
greater detail, a confocal laser scanning (CLS) microscope 
was used (Fig. 5). CLS microscopy offers improved resolu- 
Aris and I$1obcI  Yeast Nuclear Envelope Proteins  2063 Figure 5. Confocal laser scanning immunofluorescence microscopy. Fleischmann's yeast were prepared as in Fig. 4. Two specimen fields 
at different focal planes are shown (a and b). The image was electronically magnified and enhanced. Bar, 4 ~m. 
tion of detail compared to standard microscopy because of 
the reduction of the out-of-focus epifluorescence above and 
below the focal plane (27).  Examination of optical sections 
'~1.0 t~m in thickness was coupled with limited electronic im- 
age enhancement to achieve optimal definition of staining 
features. This imaging system shows that the immunofluores- 
cence is distributed in a fashion that appears both punctate 
and patchy, with notable fluorescence intensity located at the 
nuclear envelope (Fig. 5). We were unable to obtain images 
from optical sections <~1.0/zm in thickness because of the 
limited fluorescence intensity seen with the mAb 414. In ad- 
dition, we found that the nucleus could be imaged with about 
two to three serial optical sections (not shown). This is prob- 
ably due to flattening of the nucleus during preparation of 
yeast cells for microscopy. 
These  immunofluorescence findings  are consistent with 
the immunoblotting and immunoprecipitation experiments. 
Moreover, yeast cells prepared for immunofluorescence ex- 
periments were harvested from a rapidly growing yeast cul- 
ture.  All stages of the cell cycle are present. Interestingly, 
different stages of  the cell cycle show virtually identical stain- 
ing patterns (Figs. 4 and 5). The punctate and patchy staining 
pattern  was  observed consistently in  many  fields of yeast 
cells examined (not shown).  Hence, the distribution of the 
protein species that cross react with mAb 414 does not ap- 
pear to undergo dramatic cell cycle specific changes. 
lramunoelectron Microscopic Localization to the 
Nuclear Envelope 
The fluorescence staining  results  suggested that mAb 414 
reacted  with  the  nuclear  envelope,  and  that  the  discrete 
points of fluorescence may represent pore complex staining. 
To achieve ultrastructural localization, we embedded puri- 
fied nuclei in the hydrophilic resin LR White and performed 
postembedding immunoelectron microscopy. Lowicryl was 
also used, but LR White gave the best preservation of the 
yeast epitope and was used routinely. Colloidal gold particles 
(10 nm) coated with a goat anti-mouse antibody serve as a 
marker for the distribution of mAb 414. 
Postembedding  immunoelectron microscopy with  mAb 
414 shows occurrence of gold particle label primarily over 
the nuclear envelope (Fig. 6, a-e).  In typical control sam- 
ples, where no mAb was used, no gold particles were ob- 
served over the nucleus (Fig.  6 f).  Infrequently observed 
gold particles in control samples appeared to be distributed 
at random over the nucleus (not shown).  The locations of 
gold particles in sections from 50 nuclei were surveyed, and 
the data collated. This analysis shows that the abundance of 
gold labeling occurs at the nuclear envelope (Fig. 7).  The 
nuclei had  an average diameter of •1.6  #m.  The average 
number of gold particles per nucleus was 4.42, with a range 
of 2-12. 
In the postembedding experiment, a small number of gold 
particles were not positioned directly over the envelope, but 
were located within 60 nm distance of either side of the nu- 
clear envelope (Fig. 7). We have observed that the envelope 
is not always preserved intact in nuclei prepared for electron 
microscopy. Nuclei may have portions of the envelope sepa- 
rated from underlying chromatin or nucleolus (not shown). 
In addition, pore complexes are not readily visualized.  In 
general, this may be due to the fact that the nuclear envelope 
and  pore complexes in  yeast are  relatively fragile and/or 
poorly preserved. 
To  supplement  the  postembedding  approach  using  LR 
White, we labeled nuclei before embedding and processed 
samples  using  standard  methods.  Pore complexes may be 
seen after nuclei are processed using standard methods for 
glutaraldehyde  fixation,  postfixation  with  osmium,  and 
embedding in a hydrophobic resin (1). However, the preser- 
vation of pore complex morphology in yeast is not as good 
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and embedding shows decoration of pore complexes (g-i).  Pore complexes are designated by brackets. Bars, 0.5 #m. 
as  that  observed  in  higher  eucaryotic cells.  Nuclei  were 
fixed, attached to dishes, permeabilized with TX-100, probed 
with antibody, and prepared for EM (Fig. 6, g-i).  Treatment 
with TX-100 solubilizes the membranes of the nuclear enve- 
lope. The position of the outer membrane is marked by a row 
of ribosomes that remain. Pore complexes may be identified 
by virtue of their position in the envelope, dense staining 
property, and apparent diameter ('~100 nm). Colloidal gold 
(5  nm) secondary antibody appears to decorate pore com- 
plexes and to localize the mAb 414 to these structures (Fig. 
6, g-i).  We note that although the majority of the pore com- 
plexes were decorated with colloidal gold, not every pore 
complex was labeled, and some of the colloidal gold parti- 
cles appeared juxtaposed to the nuclear envelope. 
Discussion 
In this report, we have identified two proteins in the yeast nu- 
cleus,  which cross-react with a  monoclonal antibody that 
recognizes mammalian pore complex proteins. In rat liver 
nuclei, this monoclonal recognizes proteins of Mr 62,  175, 
and 270 kD and decorates pore complexes by immunoelec- 
tron microscopy (3, 4). We find that the two proteins of 110 
and 95 kD, termed pll0 and p95, are components of the yeast 
nucleus by  immunoblotting and  subcellular  fractionation. 
These two polypeptides are not detectable by immunoblot- 
ting nonnuclear fractions including a cytosolic fraction, or 
fractions containing a mixture of membranes from the vacu- 
ole, plasma membrane, and endoplasmic reticulum. Immu- 
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Figure 7. Distribution of immunogold label on yeast nuclei. The lo- 
cations of colloidal gold particles were determined for sections of 
50 nuclei subjected to postembedding immunogold labeling as in 
Fig. 6. The nuclear envelope (E) marks the zero distance point on 
the abscissa. The nuclear (N) and cytoplasmic (C) faces of the 
envelope are designated. 
noprecipitation with  mAb 414  from a  crude radiolabeled 
yeast lysate shows  that a number of proteins bind to mAb 
414. The major proteins in the mAb 414 immunoprecipitate 
are pll0, p95, and a ,x,55-kD  protein or group of proteins. 
Immunoprecipitations from radiolabeled yeast cell subfrac- 
tions show that pll0 and p95 are exclusively localized in the 
nucleus,  but that  the  •55-kD  protein(s)  appear(s)  in  the 
cytosolic compartment. 
Fractionation of nuclei demonstrates that the majority of 
pll0 cosediments with the nuclear envelope fraction after 
DNase digestion, which releases the majority of the histones 
into the soluble fraction, p110 is released from nuclear enve- 
lopes by exposure to a high (1 M) salt concentration. Thus, 
p110 does not fractionate like an integral membrane protein. 
For unknown reasons, the detectability of p95 by immuno- 
blotting was reduced during nuclear fractionation, and the 
fractionation behavior of this protein was not followed. The 
fractionation behavior of p110 does not exclude the possibil- 
ity  that  pll0  participates  in  interactions  with  other  in- 
tranuclear proteins or structures. For example, the nucleolar 
protein p38 exhibits fractionation behavior similar to pll0 
(1). However, p110 shows fractionation properties similar to 
the rat liver pore complex protein p62, which is solubilized 
from nuclear envelopes with 0.5 M NaCI (3). The disposi- 
tion of pll0 in nuclear fractionation experiments is consis- 
tent with association of p110 with the yeast nuclear envelope. 
Immunofluorescence microscopy  with  mAb  414  shows 
staining of the nucleus in yeast and a faint staining dispersed 
throughout the cytosol. The faint cytosolic staining probably 
corresponds to the intracellular distribution of the '~55-kD 
protein(s) recognized by mAb 414. The nuclear staining pat- 
tern most likely represents the intracellular location of p110 
and/or p95.  Identical results are obtained in polyploid and 
haploid yeast strains, and in isolated nuclei. The staining pat- 
tern appears qualitatively the same in cells in different stages 
of the cell cycle. The maintenance of a continuous nuclear 
envelope during  closed mitosis  in  yeast argues  that pore 
complex structure is maintained intact throughout mitosis as 
well (2, 9). The nuclear staining pattern obtained with mAb 
414 is different from the crescent staining pattern diagnostic 
of components of the yeast nucleolus, such as p38 (1). 
The small size of the yeast nucleus makes it difficult to re- 
solve this fluorescence staining pattern. We used the CLS 
microscopic  technique  with  mAb  414  to  distinguish  the 
punctate staining more clearly, and demonstrate preferential 
localization of fluorescence to regions of the nuclear enve- 
lope. CLS microscopy has been shown to produce high reso- 
lution immunofluorescence images (27).  The punctate and 
patchy, partially rim staining pattern in yeast is similar to the 
punctate rim staining pattern observed in higher eucaryotic 
cells (3, 23,  25). This punctate rim staining in higher cells 
has been used as one criterion for the identification of pore 
complex  proteins  (3).  The  more  discretely  punctate  im- 
munofluorescence seen in animal cells in tissue culture is 
discerned at lower magnification. The poorer resolution of 
this punctate rim staining pattern in yeast is probably due to 
the fact that the yeast nucleus (2-6/xm in diameter) is much 
smaller than that in animal cells, and is partially flattened 
during specimen preparation for microscopy. By compari- 
son, an image from a focal plane through the middle of an 
animal cell nucleus (20-50 #m in diameter) is more readily 
obtained. 
Immunoelectron microscopy shows  that mAb 414 recog- 
nizes proteins that are localized to the nuclear envelope in 
yeast.  Considering  the  biochemical  immunoreactivity of 
mAb 414, the most likely interpretation of the labeling of the 
nuclear envelope is that this is the location ofp110 and/or p95 
in the yeast nucleus. Moreover, labeling of structures resem- 
bling pore complexes suggests that p110 and/or p95 are com- 
ponents of the yeast pore complex. The immunogold labeling 
of pores may correspond to the punctate immunofluores- 
cence observed. Localization of pll0 and/or p95 to pores, a 
group of pores, or to the envelope may correspond to the 
punctate and patchy pattern of immunofluorescence. 
Despite the examination of several variables in the prepa- 
ration of nuclei for electron microscopy, pore complex mor- 
phology  in  isolated  yeast  nuclei  is  preserved  relatively 
poorly compared to that obtained in higher eucaryotic cells, 
as judged by the two methods for immunoelectron micros- 
copy that we have used. This may reflect suboptimal condi- 
tions for pore complex preservation during the isolation of 
nuclei or preparation for EM, or may suggest that the pore 
complex in yeast is  relatively fragile. Perhaps,  pore com- 
plexes in yeast are more "plastic" than their counterparts in 
higher cells due to, for example, the requirements of closed 
mitosis. 
Proteins similar in mass to pll0 and p95 have been re- 
ported in rat liver and Chinese hamster ovary (CHO) cells 
(23, 25). Snow et al. (25) have generated three monoclonal 
antibodies  that  react  with  a  100-kD  protein,  which  is 
modified by O-linked N-acetyl-glucosamine, among others in 
rat liver nuclei. A monoclonal isolated by Park et al.  (23) 
recognizes a  ll0-kD protein. However, considering that in 
a number of cases a single monoclonal recognizes a number 
of  pore  proteins  spanning  a  broad  range  of  molecular 
weights, it is improbable that homologies between yeast and 
mammalian pore complex proteins can be assigned on the 
basis of molecular weight alone. The pore complex proteins 
identified in mammalian cells appear to have in common the 
possession of one or more O-linked N-acetyl-glucosamine 
The Journal of Cell Biology. Volume  108, 1989  2066 residues (11). The sugar moiety contributes  to the epitopes 
recognized by certain monoclonals, but is not the sole epi- 
tope (11). This raises the possibility that p110 and p95 in yeast 
are glycosylated in an analogous fashion. Preliminary results 
indicate that wheat germ agglutinin-Sepharose precipitates 
from radiolabeled  yeast nuclei two proteins,  among others, 
that comigrate  on SDS gels with  pll0 and p95  (Aris and 
Blobel,  unpublished  results). 
Further characterization of p110 and p95 will better define 
additional  similarities,  if any, between the yeast and mam- 
malian proteins recognized by mAb 414. The production of 
antibody reagents specific for pl l0 and p95 will probably al- 
low more definitive ultrastructural localization of these two 
polypeptides, as well as enabling  us to distinguish  between 
the individual  properties of each protein.  The identification 
of pll0 and p95  suggests  that certain  domains of nuclear 
envelope proteins,  and more specifically  pore complex pro- 
teins, are identical in yeast and mammalian cells. Monoclo- 
nal antibodies  directed against other mammalian pore pro- 
teins may cross-react with pore complex proteins from yeast, 
and provide insight into pore structure and function in both 
systems. 
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